Tags: KIMMTRAKNICEuveal melanomamelanomabiomarker
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | AMBLor prognostic melanoma biomarker receives UKCA Mark - 4 months ago | |
| 2 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 10 months ago FDA OKs First Cellular Therapy for Melanoma - 11 months ago Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC - about 1 year ago | |
| 3 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 4 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 5 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Breast Cancer Highlights From ASCO 2024 - 6 months ago | |
| 6 | Randy Dotinga MedPage Today Indie scribbler, advocate.
Board member, @ahcj. San Diego | ||
| 7 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | The latest updates on cancer research from the weekend - 9 months ago | |
| 8 | Judy George MedPage Today Medical reporter, writer. | Skin Test Detects Parkinson's and Other Synucleinopathies - 9 months ago | |
| 9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | Black Diamond looks to outwit cancer mutations - 10 months ago | |
| 10 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Defining the Triple Negative Breast Cancer Morpholome - 10 months ago |